CY1107632T1 - Διαδικασια για την παρασκευη μιας θρομβινης στην οποια εχουν αδρανοποιηθει οι ιοι - Google Patents

Διαδικασια για την παρασκευη μιας θρομβινης στην οποια εχουν αδρανοποιηθει οι ιοι

Info

Publication number
CY1107632T1
CY1107632T1 CY20071100677T CY071100677T CY1107632T1 CY 1107632 T1 CY1107632 T1 CY 1107632T1 CY 20071100677 T CY20071100677 T CY 20071100677T CY 071100677 T CY071100677 T CY 071100677T CY 1107632 T1 CY1107632 T1 CY 1107632T1
Authority
CY
Cyprus
Prior art keywords
thrombine
incredible
viruses
preparing
procedure
Prior art date
Application number
CY20071100677T
Other languages
English (en)
Inventor
Caroline Connolly
Christopher Hardway
David Evans
Peter Feldman
Original Assignee
Nhs Blood And Transplant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nhs Blood And Transplant filed Critical Nhs Blood And Transplant
Publication of CY1107632T1 publication Critical patent/CY1107632T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μία μέθοδος για την παρασκευή θρομβίνης στην οποία έχουν αδρανοποιηθεί οι ιοί που περιλαμβάνει αδρανοποίηση των ιών ενός διαλύματος που συνιστάται σε προθρομβίνη και παράγοντα Χ με τη χρήση επεξεργασίας διαλύτη - απορρυπαντικού, τοποθέτηση της προθρομβίνης και του παράγοντα Χ σε ένα μέσο ανταλλαγής ανιόντων πλύση του μέσου προκειμένου να απομακρυνθούν τα αντιδραστήρια που χρησιμοποιήθηκαν για την αδρανοποίηση ιών με επεξεργασία διαλύτη-απορρυπαντικού και ενεργοποίηση της προθρομβίνης στο μέσο προκειμένου να σχηματίσει θρομβίνη με την προσθήκη ιόντων μετάλλου, κατά προτίμηση ιόντων ασβεστίου. Η θρομβίνη είναι τότε, κατά προτίμηση, επιλεκτικά εκλούσα από το μέσο ανταλλαγής ανιόντων.
CY20071100677T 2002-07-10 2007-05-18 Διαδικασια για την παρασκευη μιας θρομβινης στην οποια εχουν αδρανοποιηθει οι ιοι CY1107632T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216002.6A GB0216002D0 (en) 2002-07-10 2002-07-10 Process and composition
EP03738334A EP1520018B1 (en) 2002-07-10 2003-07-07 Process for producing a virus-inactivated thrombin preparation

Publications (1)

Publication Number Publication Date
CY1107632T1 true CY1107632T1 (el) 2013-04-18

Family

ID=9940204

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100677T CY1107632T1 (el) 2002-07-10 2007-05-18 Διαδικασια για την παρασκευη μιας θρομβινης στην οποια εχουν αδρανοποιηθει οι ιοι

Country Status (19)

Country Link
US (1) US8435779B2 (el)
EP (1) EP1520018B1 (el)
JP (1) JP4445386B2 (el)
AT (1) ATE354648T1 (el)
AU (1) AU2003244858B2 (el)
BR (1) BRPI0312522B8 (el)
CA (1) CA2491718C (el)
CY (1) CY1107632T1 (el)
DE (1) DE60311990T2 (el)
EC (1) ECSP055586A (el)
ES (1) ES2282644T3 (el)
GB (1) GB0216002D0 (el)
IL (3) IL165989A0 (el)
MX (1) MXPA05000393A (el)
NO (1) NO20050090L (el)
NZ (1) NZ537502A (el)
PL (1) PL208219B1 (el)
PT (1) PT1520018E (el)
WO (1) WO2004007707A1 (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2572327A1 (en) * 2004-06-29 2006-02-02 Reliance Life Sciences Pvt. Ltd. Process for the preparation of virus-safe biological fluids
EP1685852A1 (en) * 2005-02-01 2006-08-02 Fondation pour la Recherche Diagnostique Set of disposable bags for viral inactivation of biological fluids
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
US20070148151A1 (en) 2005-07-29 2007-06-28 Martin Frink Processes for the manufacture and use of pancreatin
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
PL2027263T3 (pl) * 2006-05-22 2013-01-31 Abbott Laboratories Gmbh Sposób separacji i określenia wiremii w próbce pankreatyny
US7774628B2 (en) * 2006-05-25 2010-08-10 Foundry Networks, Inc. Enabling/disabling power-over-ethernet software subsystem in response to power supply status
KR20100134078A (ko) * 2008-04-16 2010-12-22 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 트롬빈 고정화 생체 흡수성 시트 제제의 제조방법
JP5442310B2 (ja) * 2009-04-23 2014-03-12 旭化成メディカル株式会社 トロンビン溶液の調製方法
US8945895B2 (en) * 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
AU2015252061A1 (en) * 2009-07-31 2015-11-19 Baxalta GmbH Method for Purifying Recombinant ADAMTS13 and Other Proteins and Compositions Thereof
SE1050124A1 (sv) * 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
CN102357259A (zh) * 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
JP6297029B2 (ja) * 2012-05-31 2018-03-20 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 多様な官能基を有する粒子による免疫グロブリンｇ調製物のクロマトグラフィー精製
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
CN113754757A (zh) * 2021-07-01 2021-12-07 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
EP0443724B1 (en) * 1990-02-20 1999-03-17 Baxter International Inc. Viral-safe purified human thrombin
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
DE4137996A1 (de) * 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates
AT397390B (de) * 1992-04-06 1994-03-25 Immuno Ag Verfahren zur spaltung von proteinen
GB9503750D0 (en) * 1995-02-24 1995-04-12 Common Services Agency Thrombin preparation
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
US6245548B1 (en) * 2000-03-09 2001-06-12 American National Red Cross Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material

Also Published As

Publication number Publication date
DE60311990T2 (de) 2007-11-08
BR0312522A (pt) 2005-04-19
IL165989A (en) 2010-11-30
DE60311990D1 (de) 2007-04-05
GB0216002D0 (en) 2002-08-21
IL165989A0 (en) 2006-01-15
NZ537502A (en) 2007-12-21
WO2004007707A1 (en) 2004-01-22
IL201146A (en) 2011-05-31
BRPI0312522B1 (pt) 2019-01-02
EP1520018A1 (en) 2005-04-06
PT1520018E (pt) 2007-04-30
BRPI0312522B8 (pt) 2021-05-25
AU2003244858A1 (en) 2004-02-02
US20060134769A1 (en) 2006-06-22
CA2491718C (en) 2013-10-22
ATE354648T1 (de) 2007-03-15
CA2491718A1 (en) 2004-01-22
US8435779B2 (en) 2013-05-07
AU2003244858B2 (en) 2008-01-31
ES2282644T3 (es) 2007-10-16
MXPA05000393A (es) 2005-07-22
JP2005532073A (ja) 2005-10-27
EP1520018B1 (en) 2007-02-21
NO20050090L (no) 2005-04-08
JP4445386B2 (ja) 2010-04-07
PL374747A1 (en) 2005-10-31
ECSP055586A (es) 2005-07-06
PL208219B1 (pl) 2011-03-31

Similar Documents

Publication Publication Date Title
CY1107632T1 (el) Διαδικασια για την παρασκευη μιας θρομβινης στην οποια εχουν αδρανοποιηθει οι ιοι
CY1119265T1 (el) Κατασκευες νανοσωματων τρισθενους αντι ανθρωπινου αναπνευστικου συγκυτιακου ιου (hrsv) για την προληψη και/ή θεραπεια λοιμωξεων της αναπνευστικης οδου
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
SI1685243T1 (sl) Imortalizirane ptičje celične linije za produkcijo virusov
MX342639B (es) Virus de la influenza recombinantes de alta titulacion para vacunas y terapia genica.
WO2007095318A3 (en) Influenza antigens, vaccine compositions, and related methods
CY1114356T1 (el) Αναστολεις του ιου της ηπατιτιδας c
DK1404821T3 (da) Fremgangsmåde til fremstilling af L-aminosyrer under avnendelse af stammer fra familien Enterobacteriaceae
WO2007024941A3 (en) Polyvalent vaccine
WO2006110831A3 (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
WO2021243122A8 (en) Engineered coronavirus spike (s) protein and methods of use thereof
MA27581A1 (fr) Vaccin a pseudo-particules virales de la proteine l1 des papillomavirus 16 et 18
EA201390856A1 (ru) Инактивация вирусов с применением улучшенного способа растворитель-детергент
WO2010047830A3 (en) Agents for hcv treatment
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
WO2007084435A8 (en) Methods for treating hepatitis c
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
DE60024100D1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
AU2002337083A1 (en) Vaccinia virus mva-e3l-knockout-mutants and use thereof
WO2004043404A3 (en) Process for designing inhibitors of influenza virus non-structural protein 1
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
DE60231821D1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
IL175558A0 (en) A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
TR200403039T1 (tr) Seramik parçalarının süslenmesi için yöntem ve donatım ile buradan elde edilen ürünler